Progyny, Inc. Share-based Payment Arrangement, Expense
Progyny, Inc. (PGNY) reported Share-based Payment Arrangement, Expense of $20.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-07
- Progyny, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $20.48M, a 36.76% decline year-over-year.
- Progyny, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $19.72M, a 39.34% decline year-over-year.
- Progyny, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $34.80M, a 12.77% increase year-over-year.
- Progyny, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $32.17M, a 3.04% decline year-over-year.
- Progyny, Inc. share-based payment arrangement, expense for fiscal 2025 was $131.87M, a 2.92% increase from fiscal 2024.
- Progyny, Inc. share-based payment arrangement, expense for fiscal 2024 was $128.13M, a 4.50% increase from fiscal 2023.
- Progyny, Inc. share-based payment arrangement, expense for fiscal 2023 was $122.61M, a 21.70% increase from fiscal 2022.
- Progyny, Inc. share-based payment arrangement, expense for fiscal 2022 was $100.75M, a 198.90% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.48M 10-Q · filed 2026-08-07 | $40.20M 10-Q · filed 2026-08-07 | $75.00M derived: sum of 3 quarters · filed 2026-08-07 | $107.17M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $19.72M 10-Q · filed 2026-05-08 | $54.52M derived: sum of 2 quarters · filed 2026-05-08 | $86.69M derived: sum of 3 quarters · filed 2026-05-08 | $119.08M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $34.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $66.97M derived: sum of 2 quarters · filed 2026-02-27 | $99.36M derived: sum of 3 quarters · filed 2026-08-07 | $131.87M 10-K · filed 2026-02-27 |
| 2025-09-30 | $32.17M 10-Q · filed 2025-11-07 | $64.56M derived: sum of 2 quarters · filed 2026-08-07 | $97.07M 10-Q · filed 2025-11-07 | $127.93M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $32.38M 10-Q · filed 2026-08-07 | $64.89M 10-Q · filed 2026-08-07 | $95.75M derived: sum of 3 quarters · filed 2026-08-07 | $128.94M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $32.51M 10-Q · filed 2026-05-08 | $63.37M derived: sum of 2 quarters · filed 2026-05-08 | $96.55M derived: sum of 3 quarters · filed 2026-05-08 | $129.59M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $30.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $64.04M derived: sum of 2 quarters · filed 2026-02-27 | $97.08M derived: sum of 3 quarters · filed 2026-02-27 | $128.13M 10-K · filed 2026-02-27 |
| 2024-09-30 | $33.18M 10-Q · filed 2025-11-07 | $66.22M derived: sum of 2 quarters · filed 2025-11-07 | $97.27M 10-Q · filed 2025-11-07 | $126.07M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $33.04M 10-Q · filed 2025-08-08 | $64.09M 10-Q · filed 2025-08-08 | $92.89M derived: sum of 3 quarters · filed 2026-02-27 | $124.14M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $31.05M 10-Q · filed 2025-05-09 | $59.85M derived: sum of 2 quarters · filed 2026-02-27 | $91.10M derived: sum of 3 quarters · filed 2026-02-27 | $122.86M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $28.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $60.05M derived: sum of 2 quarters · filed 2026-02-27 | $91.80M derived: sum of 3 quarters · filed 2026-02-27 | $122.61M 10-K · filed 2026-02-27 |
| 2023-09-30 | $31.25M 10-Q · filed 2024-11-12 | $63.00M derived: sum of 2 quarters · filed 2024-11-12 | $93.81M 10-Q · filed 2024-11-12 | $123.11M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $31.75M 10-Q · filed 2024-08-07 | $62.56M 10-Q · filed 2024-08-07 | $91.86M derived: sum of 3 quarters · filed 2025-03-03 | $115.16M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $30.81M 10-Q · filed 2024-05-10 | $60.10M derived: sum of 2 quarters · filed 2025-03-03 | $83.40M derived: sum of 3 quarters · filed 2025-03-03 | $107.06M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $29.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $52.59M derived: sum of 2 quarters · filed 2025-03-03 | $76.25M derived: sum of 3 quarters · filed 2025-03-03 | $100.75M 10-K · filed 2025-03-03 |
| 2022-09-30 | $23.30M 10-Q · filed 2023-11-08 | $46.95M derived: sum of 2 quarters · filed 2023-11-08 | $71.45M 10-Q · filed 2023-11-08 | $86.46M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $23.65M 10-Q · filed 2023-08-04 | $48.15M 10-Q · filed 2023-08-04 | $63.16M derived: sum of 3 quarters · filed 2024-02-29 | $70.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $24.50M 10-Q · filed 2023-05-09 | $39.51M derived: sum of 2 quarters · filed 2024-02-29 | $46.66M derived: sum of 3 quarters · filed 2024-02-29 | $53.17M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $15.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $22.16M derived: sum of 2 quarters · filed 2024-02-29 | $28.67M derived: sum of 3 quarters · filed 2024-02-29 | $33.71M 10-K · filed 2024-02-29 |
| 2021-09-30 | $7.15M 10-Q · filed 2022-11-04 | $13.66M derived: sum of 2 quarters · filed 2022-11-04 | $18.70M 10-Q · filed 2022-11-04 | $22.86M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $6.52M 10-Q · filed 2022-08-05 | $11.55M 10-Q · filed 2022-08-05 | $15.71M derived: sum of 3 quarters · filed 2023-03-01 | $18.78M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $5.03M 10-Q · filed 2022-05-06 | $9.19M derived: sum of 2 quarters · filed 2023-03-01 | $12.27M derived: sum of 3 quarters · filed 2023-03-01 | $15.81M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $7.23M derived: sum of 2 quarters · filed 2023-03-01 | $10.77M derived: sum of 3 quarters · filed 2023-03-01 | $12.82M 10-K · filed 2023-03-01 |
| 2020-09-30 | $3.07M 10-Q · filed 2021-11-08 | $6.61M derived: sum of 2 quarters · filed 2021-11-08 | $8.66M 10-Q · filed 2021-11-08 | $10.51M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $3.54M 10-Q · filed 2021-08-06 | $5.59M 10-Q · filed 2021-08-06 | $7.44M derived: sum of 3 quarters · filed 2022-03-01 | $9.12M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.05M 10-Q · filed 2021-05-07 | $3.90M derived: sum of 2 quarters · filed 2022-03-01 | $5.58M derived: sum of 3 quarters · filed 2022-03-01 | $6.59M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.53M derived: sum of 2 quarters · filed 2022-03-01 | $4.54M derived: sum of 3 quarters · filed 2022-03-01 | $5.06M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.68M 10-Q · filed 2020-11-06 | $2.69M derived: sum of 2 quarters · filed 2020-11-06 | $3.21M 10-Q · filed 2020-11-06 | $3.90M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.01M 10-Q · filed 2020-08-07 | $1.53M 10-Q · filed 2020-08-07 | $2.22M derived: sum of 3 quarters · filed 2021-03-01 | $3.02M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $517.00K 10-Q · filed 2020-05-14 | $1.21M derived: sum of 2 quarters · filed 2021-03-01 | $2.01M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.49M derived: sum of 2 quarters · filed 2021-03-01 | $3.00M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $796.00K 10-Q · filed 2019-12-06 | $2.30M 10-Q · filed 2019-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |